chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Malaise, Nausea
Clinical narrative: Nausea; tiredness; headache; joint pain; feeling unwell; injection site pain; This is a spontaneous report from a non-contactable consumer, the patient. A 60-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 30Mar2021 at 15:15(at the age of 60-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) and amoxicillin (MANUFACTURER UNKNOWN) from unknown date for unspecified indication. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 03:00 the patient experienced nausea, tiredness, headache, joint pain, feeling unwell and injection site pain. Therapeutic measures were taken as a result of reported events and advice nurse telephone call was reported. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event nausea, tiredness, headache, joint pain, feeling unwell and injection site pain was recovered on unknown date.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Nausea; tiredness; headache; joint pain; feeling unwell; injection site pain; This is a spontaneous report from a non-contactable consumer, the patient. A 60-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 30Mar2021 at 15:15(at the age of 60-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) and amoxicillin (MANUFACTURER UNKNOWN) from unknown date for unspecified indication. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 03:00 the patient experienced nausea, tiredness, headache, joint pain, feeling unwell and injection site pain. Therapeutic measures were taken as a result of reported events and advice nurse telephone call was reported. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event nausea, tiredness, headache, joint pain, feeling unwell and injection site pain was recovered on unknown date.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Hyperhidrosis, Pain
Clinical narrative: Body aches; Sweats; Chills; Headache; This is a spontaneous report from a non-contactable consumer, the patient. A 33-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the right arm on 07Apr2021 at 13:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 and known allergies to penicillin (MANUFACTURER UNKNOWN). The patient did not receive any concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the right arm on 17Mar2021 at 13:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 08Apr2021 at 03:00, approx. 18 hours after the second dose of the vaccine, the patient experienced body aches, sweats, chills and headache. The symptoms lasted for about 24 hours. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcomes of body aches, sweats, chills and headache were resolved on 09Apr2021 at 03:00.  No follow-up attempts are possible. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Headache, Irritability, Nausea
Clinical narrative: Chills; Fever; Headache; Nausea; Vomiting; Diarrhea; Irritable; This is a spontaneous report from a contactable other healthcare professional, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 24Mar2021 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included Klippel Feil syndrome, ADHD (attention deficit hyperactivity disorder), depression and vertebrae fusions. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient received unspecified medications within two weeks of the COVID-19 vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the left arm on 02Mar2021 at 16:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation and reported that she did not experience any adverse events after dose 1.The patient previously received RONDEC and CECLOR and experienced a drug allergy. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 24Mar2021 at 21:00, the patient experienced chills, fever, headache, nausea, vomiting, diarrhea and "irritable". Since the vaccination, the patient had been tested for COVID-19. On an unspecified date the patient underwent a nasal swab test and tested negative. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events chills, fever, headache, nausea, vomiting, diarrhea and irritable were resolved on an unspecified date in 2021.    No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test, Vomiting
Clinical narrative: Chills; Fever; Headache; Nausea; Vomiting; Diarrhea; Irritable; This is a spontaneous report from a contactable other healthcare professional, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 24Mar2021 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included Klippel Feil syndrome, ADHD (attention deficit hyperactivity disorder), depression and vertebrae fusions. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient received unspecified medications within two weeks of the COVID-19 vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the left arm on 02Mar2021 at 16:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation and reported that she did not experience any adverse events after dose 1.The patient previously received RONDEC and CECLOR and experienced a drug allergy. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 24Mar2021 at 21:00, the patient experienced chills, fever, headache, nausea, vomiting, diarrhea and "irritable". Since the vaccination, the patient had been tested for COVID-19. On an unspecified date the patient underwent a nasal swab test and tested negative. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events chills, fever, headache, nausea, vomiting, diarrhea and irritable were resolved on an unspecified date in 2021.    No follow-up attempts are needed. No further information is expected.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Head discomfort, Headache, Heart rate increased
Clinical narrative: Swollen lymph nodes in neck, the supraclavicular lymph node and the anterior cervical lymph node on the left side, same side as injection. The soreness and pain travel down in the arm muscle past the injection site and up into the neckbehind the ear; Accompanied by feeling feverish, chills, dizziness,headache, pressure on head and fastheart beat; Accompanied by feeling feverish, chills, dizziness,headache, pressure on head and fast heart beat; Accompanied by feeling feverish, chills, dizziness,headache, pressure on head and fast heart beat; Accompanied by feeling feverish, chills, dizziness,headache, pressure on head and fast heart beat; Accompanied by feeling feverish, chills, dizziness,headache, pressure on head and fast heart beat; Accompanied by feeling feverish, chills, dizziness,headache, pressure on head and fast heart beat; This is a spontaneous report from a non-contactable consumer, the patient. A 17-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date(at the age of 17-year-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient did not have allergies to food, medication or other products. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19 . The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 the patient experienced swollen lymph nodes in neck, the supraclavicular lymph node and the anterior cervical lymph node, on the left side, same side as had injection. Swollen nodes cause pain when moving neck and arm, and hurt to touch. The soreness and pain travel down in the arm muscle past the injection site and up into the neck behind the ear. Accompanied by feeling feverish, chills, dizziness, headache, pressure on head and fast heartbeat. Therapeutic measures were not taken as a result of the event(s). The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events Swollen lymph nodes in neck, the supraclavicular lymph node and the anterior cervical lymph node, pain, hurt to touch, feeling feverish, chills, dizziness, headache, pressure on head and fast heartbeat were not recovered at the time of report.    No follow-up attempts are possible; information about lot number cannot be obtained. No further information is expected.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pain, Pyrexia
Clinical narrative: Swollen lymph nodes in neck, the supraclavicular lymph node and the anterior cervical lymph node on the left side, same side as injection. The soreness and pain travel down in the arm muscle past the injection site and up into the neckbehind the ear; Accompanied by feeling feverish, chills, dizziness,headache, pressure on head and fastheart beat; Accompanied by feeling feverish, chills, dizziness,headache, pressure on head and fast heart beat; Accompanied by feeling feverish, chills, dizziness,headache, pressure on head and fast heart beat; Accompanied by feeling feverish, chills, dizziness,headache, pressure on head and fast heart beat; Accompanied by feeling feverish, chills, dizziness,headache, pressure on head and fast heart beat; Accompanied by feeling feverish, chills, dizziness,headache, pressure on head and fast heart beat; This is a spontaneous report from a non-contactable consumer, the patient. A 17-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date(at the age of 17-year-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient did not have allergies to food, medication or other products. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19 . The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 the patient experienced swollen lymph nodes in neck, the supraclavicular lymph node and the anterior cervical lymph node, on the left side, same side as had injection. Swollen nodes cause pain when moving neck and arm, and hurt to touch. The soreness and pain travel down in the arm muscle past the injection site and up into the neck behind the ear. Accompanied by feeling feverish, chills, dizziness, headache, pressure on head and fast heartbeat. Therapeutic measures were not taken as a result of the event(s). The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events Swollen lymph nodes in neck, the supraclavicular lymph node and the anterior cervical lymph node, pain, hurt to touch, feeling feverish, chills, dizziness, headache, pressure on head and fast heartbeat were not recovered at the time of report.    No follow-up attempts are possible; information about lot number cannot be obtained. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Blood test, Chest discomfort, Electrocardiogram, Heart rate
Clinical narrative: oxygen saturation level is sometimes in the high 80s; feel sporadic tightness in my chest on a daily basis; blood pressure was low; heart started racing. It was between 135-150 bpm for a little over 12 hours/heart rate has never completely returned to normal. It will typically vary from 68-120 bpm; heart started racing. It was between 135-150 bpm for a little over 12 hours/heart rate has never completely returned to normal. It will typically vary from 68-120 bpm; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number: EN6198), via an unspecified route of administration in the right arm on 19Feb2021 at 14:45 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included allergies to penicillin. The patient was not diagnosed with COVID-19 prior to vaccination, however, the patient believed she was a false negative for COVID-19. Concomitant medications included levothyroxine. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: EN5318) in the right arm on 29Jan2021 at 12:30 (at the age of 56-years-old) for COVID-19 immunisation. The patient previously took tetracycline and experienced allergies. The patient did not receive any other vaccine within 4 weeks of the vaccination. On 20Feb2021 at 18:00, the day after the 2nd dose in the evening, the patient's heart started racing. It was between 135-150 bpm for a little over 12 hours. The patient finally went to urgent care, and by then the heart had slowed to a regular rate. But her blood pressure was low, so she received a saline IV. The EKG and some type of blood test were both normal on Feb2021. The events required an emergency room/department or urgent care visit. To this date (13Apr2021), the patient's heart rate had never completely returned to normal. It will typically vary from 68-120 bpm, and the oxygen saturation level was sometimes in the high 80s, as of an unspecified date. The patient felt sporadic tightness in the chest on a daily basis, as of an unspecified date. The patient was waiting to be seen by a cardiologist. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events was resolved with sequel.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension, Oxygen saturation, Oxygen saturation decreased, Palpitations, SARS-CoV-2 test
Clinical narrative: oxygen saturation level is sometimes in the high 80s; feel sporadic tightness in my chest on a daily basis; blood pressure was low; heart started racing. It was between 135-150 bpm for a little over 12 hours/heart rate has never completely returned to normal. It will typically vary from 68-120 bpm; heart started racing. It was between 135-150 bpm for a little over 12 hours/heart rate has never completely returned to normal. It will typically vary from 68-120 bpm; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number: EN6198), via an unspecified route of administration in the right arm on 19Feb2021 at 14:45 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included allergies to penicillin. The patient was not diagnosed with COVID-19 prior to vaccination, however, the patient believed she was a false negative for COVID-19. Concomitant medications included levothyroxine. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: EN5318) in the right arm on 29Jan2021 at 12:30 (at the age of 56-years-old) for COVID-19 immunisation. The patient previously took tetracycline and experienced allergies. The patient did not receive any other vaccine within 4 weeks of the vaccination. On 20Feb2021 at 18:00, the day after the 2nd dose in the evening, the patient's heart started racing. It was between 135-150 bpm for a little over 12 hours. The patient finally went to urgent care, and by then the heart had slowed to a regular rate. But her blood pressure was low, so she received a saline IV. The EKG and some type of blood test were both normal on Feb2021. The events required an emergency room/department or urgent care visit. To this date (13Apr2021), the patient's heart rate had never completely returned to normal. It will typically vary from 68-120 bpm, and the oxygen saturation level was sometimes in the high 80s, as of an unspecified date. The patient felt sporadic tightness in the chest on a daily basis, as of an unspecified date. The patient was waiting to be seen by a cardiologist. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events was resolved with sequel.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Tachycardia
Clinical narrative: oxygen saturation level is sometimes in the high 80s; feel sporadic tightness in my chest on a daily basis; blood pressure was low; heart started racing. It was between 135-150 bpm for a little over 12 hours/heart rate has never completely returned to normal. It will typically vary from 68-120 bpm; heart started racing. It was between 135-150 bpm for a little over 12 hours/heart rate has never completely returned to normal. It will typically vary from 68-120 bpm; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number: EN6198), via an unspecified route of administration in the right arm on 19Feb2021 at 14:45 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included allergies to penicillin. The patient was not diagnosed with COVID-19 prior to vaccination, however, the patient believed she was a false negative for COVID-19. Concomitant medications included levothyroxine. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: EN5318) in the right arm on 29Jan2021 at 12:30 (at the age of 56-years-old) for COVID-19 immunisation. The patient previously took tetracycline and experienced allergies. The patient did not receive any other vaccine within 4 weeks of the vaccination. On 20Feb2021 at 18:00, the day after the 2nd dose in the evening, the patient's heart started racing. It was between 135-150 bpm for a little over 12 hours. The patient finally went to urgent care, and by then the heart had slowed to a regular rate. But her blood pressure was low, so she received a saline IV. The EKG and some type of blood test were both normal on Feb2021. The events required an emergency room/department or urgent care visit. To this date (13Apr2021), the patient's heart rate had never completely returned to normal. It will typically vary from 68-120 bpm, and the oxygen saturation level was sometimes in the high 80s, as of an unspecified date. The patient felt sporadic tightness in the chest on a daily basis, as of an unspecified date. The patient was waiting to be seen by a cardiologist. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events was resolved with sequel.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Oral herpes
Clinical narrative: Cold sore outbreak on lip; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Apr2021 at 09:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medication included oral birth control (MANUFACTURER UNKNOWN), taken from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021 at 12:00, the patient experienced cold sore outbreak on lip. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event cold sore outbreak on lip was not resolved at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Diarrhoea, Fatigue, Headache
Clinical narrative: Achy joints; Fatigue; Headache; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Apr2021 at 16:00 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient previously received SULFONAMIDE on an unspecified date for an unspecified indication and experienced drug allergy. Concomitant medications included simvastatin (MANUFACTURER UNKNOWN)10 mg, spironolactone (MANUFACTURER UNKNOWN) 50 mg for an unknown indication, from an unknown date and unknown if ongoing.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 08:00, the patient experienced achy joints, fatigue, headache and diarrhea. The events did not result in doctor or other healthcare professional office/clinic visit/ emergency visit. Therapeutic measures were not taken as a result of adverse events. Achy joints, fatigue and headache lasted for 2 days but diarrhea continued on 5th day also. Other symptoms subsided. The clinical outcome of the events achy joints, fatigue  was resolved on an unknown date in Apr2021while the clinical outcome of the event headache was resolved on 10Apr2021. The clinical outcome of the event diarrhea was not resolved at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: Swelling and tenderness in the lymph nodes in left under arm and left side of breast; Swelling and tenderness in the lymph nodes in left under arm and left side of breast; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 09Apr2021 at 09:30 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history reported. The patient was not aware of any known allergies to food, medications or other products. Concomitant medications included multivitamin (MANUFACTURER UNKNOWN), zingiber officinale rhizome (GINGER ROOT), curcuma longa rhizome (TURMERIC), krill oil (MANUFACTURER UNKNOWN) and "c"; all taken for unknown indications from unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 19Mar2021 at 09:30 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 22:00, the patient experienced swelling and tenderness in the lymph nodes in left under arm and left side of breast that occurred at about 36 hours after second injection. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events swelling and tenderness in the lymph nodes in left under arm and left side of breast was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal distension, Arthralgia, SARS-CoV-2 test, Weight increased
Clinical narrative: severe joint pain in left hip; Upper abdominal bloating; rapid weight gain; severe joint pain in left hip, knee and ankle; severe joint pain in left hip, knee, and ankle; severe joint pain in left hip, knee, and ankle; This is a spontaneous report from a non-contactable consumer, the patient. A 62-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 26Mar2021(at the age of 62-year-old) as a single dose for COVID-19 immunisation. Medical history included arthritis, sulfonamide allergy, sulfites allergy and covid-19. The patient did not receive concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 26Feb2021(at the age of 62-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. On 29March2021 the patient experienced upper abdominal bloating, rapid weight gain and severe joint pain in left hip, knee, and ankle. Therapeutic measures were not taken as a result of the event(s). The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. On 19Nov2020, the patient underwent lab test which included nasal swab and the result was negative. The clinical outcome of the events upper abdominal bloating, rapid weight gain and severe joint pain in left hip, knee, and ankle were not recovered/not resolved/ongoing.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Nystagmus, Vertigo
Clinical narrative: Vertigo; Dizziness; Fatigue; Eyes move side to side rapidly; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 09Apr2021 at 16:15 (at the age of 26-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021, since midnight, the patient experienced vertigo, dizziness, fatigue and with the vertigo the patient's eyes move side to side rapidly. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event vertigo, dizziness, fatigue and eyes move side to side rapidly was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Insomnia, Pyrexia
Clinical narrative: Severe insomnia.; probably fever; covered in sweat; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the arm right on 08Apr2021 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included ethinylestradiol; norgestimate (SPRINTEC), acetylsalicylic acid; caffeine; paracetamol (EXCEDRIN), trazodone (MANUFACTURER UNKNOWN), betacarotene; calcium carbonate; cyanocobalamin; folic acid; nicotinic acid; pyridoxine hydrochloride; riboflavin; sodium ascorbate; thiamine hydrochloride; tocopheryl acetate (ONE A DAY) all from an unknown date for an unspecified indication. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 18Mar2021 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, the patient experienced severe insomnia, and probably fever. Usually goes to bed around 10pm, was unable to fall asleep until 4:30am. Woke up at 6am covered in sweat. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of events severe insomnia, and probably fever, sweat was recovered on an unspecified date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling face
Clinical narrative: Large area of ovoid swelling above right eyebrow; This is a spontaneous report from a non-contactable consumer, the patient. A 54-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the right arm on 09Apr2021 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient was not allergic to any medications, food or other products. Concomitant medications included multivitamin and zinc supplement (MANUFACTURER UNKNOWN); taken for unknown indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination.  On 09Apr2021 at 19:30, the patient experienced large area of ovoid swelling above right eyebrow occurred approximately 6 hours post administration. The event resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events.  The clinical outcome of the event large area of ovoid swelling above right eyebrow was resolved on unknown date in Apr2021.   No follow-up attempts are possible. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Tinnitus
Clinical narrative: Very loud pulsating tinnitus in my right ear which started 5 days after vaccine; Feeling dizzy; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0150), via an unspecified route of administration in left arm on 05Apr2021 at 14:30 (at the age of 48 years-old) as single dose for COVID-19 immunisation. Medical history included diabetes type 2. The patient reported that she was not aware of any known allergies to medications food or other products. Concomitant medications included acetylsalicylic acid (ASPIRIN) and doxylamine succinate (UNISOM). Prior to vaccination, it was unknown if the patient was diagnosed with COVID-19; Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 09Apr2021 at 14:00, the patient reported that she had started to feel dizzy. On 10Apr2021, the patient experienced a very loud pulsating tinnitus in right ear which started 5 days after the vaccine. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event pulsating tinnitus in right ear which started 5 days after the vaccine and felt dizzy were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Hyperhidrosis
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 55-year-old (non-pregnant) female patient received an unknown dose number of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# unknown), at the age of 55, via an unspecified route of administration, left arm, on Apr 12, 2021, at 14:30, single dose, for COVID-19 immunisation. The patient has no reported medical history. The patient previously took Vicodin on an unknown date, for an unknown indication; and experienced allergy. Prior to the vaccination, patient was not diagnosed with COVID-19. Concomitant medications included Aspirin (acetylsalicylic acid/ascorbic acid); Motrin (ibuprofen); Sudafed (guaifenesin; pseudoephedrine hydrochloride); Iron; Vitamin D; all for unknown indication from unknown dates, and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On Apr 12, 2021, at 21:00, patient experienced severe diarrhea. On Apr 13, 2021, patient experienced chills and sweats. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, patient has not tested for COVID-19. The clinical outcome of the events severe diarrhea, chills, and sweats recovered on an unknown date in Apr 2021. No follow-up attempts are needed. Information about lot/batch number cannot be obtained. No further information expected.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Dry throat, Dysgeusia
Clinical narrative: Noticed after taste in my mouth; dry throat within 5 mins of the injection; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Apr2021 at 11:00(at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, allergy to pollen from trees/grasses and suffered anaphylaxis after eating food from another country. Concomitant medications included pantoprazole (MANUFACTURER UNKNOWN) and cetirizine hydrochloride (ZYRTEC); both for unknown indication and start date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 08Apr2021 at 11:15, the patient noticed after taste in mouth and also experienced dry throat within 5 mins of the injection. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the event after taste in mouth and dry throat within 5 mins of the injection were recovered on an unknown date in 2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Oropharyngeal pain, Pain
Clinical narrative: Sore throat; Tiredness; soreness; This is a spontaneous report from a non-contactable consumer, the patient. A 47-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration on an unknown date in 2021 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On an unknown date, the patient experienced sore throat 3 days after 2nd vaccination. Only side effects the first 3 days were soreness and tiredness. The event resulted in doctor or other healthcare professional office/clinic visit. It was unknown if patient received any treatment for the events. The clinical outcome of the events sore throat, soreness and tiredness were unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Induration, Pruritus, Tenderness
Clinical narrative: Hives on injection arm just below the injection site; Affected area which roughly covers a 4 x 2 inch surface area red and hard and hot to the touch; Affected area which roughly covers a 4 x 2 inch surface area red and hard and hot to the touch; Affected area which roughly covers a 4 x 2 inch surface area red and hard and hot to the touch; The area is both itchy and tender.; The area is both itchy and tender.; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: IN8730) via an unspecified route of administration in the left arm on 23Mar2021 at 15:15 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and chronic low vitamin d levels. The patient had no known allergies to medications, food or other products. Concomitant medications included melatonin (MANUFACTURER UNKNOWN), vitamin d nos (MANUFACTURER UNKNOWN), ascorbic acid (VITAMIN C), cyanocobalamin (VITAMIN B12) and multivitamin; all for an unknown date for unknown indication. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 23Mar2021 at 19:00, the patient experienced hives on injection arm just below the injection site. Affected area which roughly covers a 4 x 2-inch surface area was red, hard and hot to the touch. The area was both itchy and tender. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were not taken as a result of the reported event. The clinical outcome of the event hives on injection arm just below the injection site, affected area which roughly covers a 4 x 2-inch surface area red and hard and hot to the touch, itchy and tender were not resolved at the time of this report. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 13Apr2021 at 15:15 (at the age of 46-years-old) as a single dose for COVID-19 immunisation.   No follow-up attempts are needed. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Hives on injection arm just below the injection site; Affected area which roughly covers a 4 x 2 inch surface area red and hard and hot to the touch; Affected area which roughly covers a 4 x 2 inch surface area red and hard and hot to the touch; Affected area which roughly covers a 4 x 2 inch surface area red and hard and hot to the touch; The area is both itchy and tender.; The area is both itchy and tender.; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: IN8730) via an unspecified route of administration in the left arm on 23Mar2021 at 15:15 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and chronic low vitamin d levels. The patient had no known allergies to medications, food or other products. Concomitant medications included melatonin (MANUFACTURER UNKNOWN), vitamin d nos (MANUFACTURER UNKNOWN), ascorbic acid (VITAMIN C), cyanocobalamin (VITAMIN B12) and multivitamin; all for an unknown date for unknown indication. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 23Mar2021 at 19:00, the patient experienced hives on injection arm just below the injection site. Affected area which roughly covers a 4 x 2-inch surface area was red, hard and hot to the touch. The area was both itchy and tender. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were not taken as a result of the reported event. The clinical outcome of the event hives on injection arm just below the injection site, affected area which roughly covers a 4 x 2-inch surface area red and hard and hot to the touch, itchy and tender were not resolved at the time of this report. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 13Apr2021 at 15:15 (at the age of 46-years-old) as a single dose for COVID-19 immunisation.   No follow-up attempts are needed. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal distension, Diarrhoea, Flatulence
Clinical narrative: Diarrhea; gas; bloating; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 30Mar2021 at 08:00 (at the age of 69-years-old) as a dose for COVID-19 immunisation. Patient also received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 02Mar2021 at 08:00 (at the age of 69-years-old) as a dose for COVID-19 immunisation. Medical history included none. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN) from an unknown date for an unspecified indication. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Mar2021 at 10:00, the patient experienced diarrhea, gas, bloating started 6 days after first vaccine and was continuing after second vaccine. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events diarrhea, gas, bloating started 6 days after first vaccine was not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.